Short answer. Condition 6 requires this statement on the product labeling: "This is a compounded drug product. Not for resale." [2]. If that sentence is missing, that condition is not met. As of Oct 29, 2026.

What the sentence does

It tells you two facts the policy wants on the package.

• The product is compounded. Compounded drugs are not FDA-approved. FDA does not review their safety, effectiveness, or quality before marketing [1].

• It is not for resale. The policy is about a patient-specific compounded product, not a bottle you buy in bulk and sell on [1][2].

The policy also says the patient's labeling should explain how to report adverse events and problems with identity, strength, purity, or quality [2]. A bare slogan is not that instruction.

What the sentence does not do

It does not mean the peptide works. It does not put the peptide on the 503A bulks list. It does not turn a "research use only" sticker into a legal product. Those are different labels. The research-use sticker is the seller saying the product is not for people. The sentence in this policy is for a compounded drug from a covered compounder [1][2]. See Prescription vs research peptides.

If someone shows you a vial of one of the six and the words "compounded" and "not for resale" are not on it, they are not showing you the label this condition describes.

FAQ

Is the wording flexible? The policy prints the sentence in quotation marks [2]. Ask for that sentence, not a paraphrase.

Does the label make it FDA-approved? No. The label says it is compounded. The notice says compounded drugs are not FDA-approved [1].

Sources

1. HHS notice, FR Doc. 2026-22192, filed Oct 28, 2026. https://public-inspection.federalregister.gov/2026-22192.pdf

2. HHS policy, conditions 5 and 6. https://www.hhs.gov/sites/default/files/hhs-503a-peptide-enforcement-discretion-policy-appendix-b.pdf

Sommar Club does not prescribe or sell these six. Education only. Not medical or legal advice. As of Oct 29, 2026.